Crosstalk among mitophagy, pyroptosis, ferroptosis, and necroptosis in central nervous system injuries

Copyright © 2024 Copyright: © 2024 Neural Regeneration Research..

Central nervous system injuries have a high rate of resulting in disability and mortality; however, at present, effective treatments are lacking. Programmed cell death, which is a genetically determined form of active and ordered cell death with many types, has recently attracted increasing attention due to its functions in determining the fate of cell survival. A growing number of studies have suggested that programmed cell death is involved in central nervous system injuries and plays an important role in the progression of brain damage. In this review, we provide an overview of the role of programmed cell death in central nervous system injuries, including the pathways involved in mitophagy, pyroptosis, ferroptosis, and necroptosis, and the underlying mechanisms by which mitophagy regulates pyroptosis, ferroptosis, and necroptosis. We also discuss the new direction of therapeutic strategies targeting mitophagy for the treatment of central nervous system injuries, with the aim to determine the connection between programmed cell death and central nervous system injuries and to identify new therapies to modulate programmed cell death following central nervous system injury. In conclusion, based on these properties and effects, interventions targeting programmed cell death could be developed as potential therapeutic agents for central nervous system injury patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:19

Enthalten in:

Neural regeneration research - 19(2024), 8 vom: 01. März, Seite 1660-1670

Sprache:

Englisch

Beteiligte Personen:

Zhang, Li [VerfasserIn]
Hu, Zhigang [VerfasserIn]
Li, Zhenxing [VerfasserIn]
Lin, Yixing [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Revised 25.03.2024

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.4103/1673-5374.389361

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365939218